Product NDC: | 23155-115 |
Proprietary Name: | Glipizide and Metformin HCl |
Non Proprietary Name: | Glipizide and Metformin HCl |
Active Ingredient(s): | 2.5; 250 mg/1; mg/1 & nbsp; Glipizide and Metformin HCl |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 23155-115 |
Labeler Name: | Heritage Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078728 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100629 |
Package NDC: | 23155-115-10 |
Package Description: | 1000 TABLET, FILM COATED in 1 BOTTLE (23155-115-10) |
NDC Code | 23155-115-10 |
Proprietary Name | Glipizide and Metformin HCl |
Package Description | 1000 TABLET, FILM COATED in 1 BOTTLE (23155-115-10) |
Product NDC | 23155-115 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Glipizide and Metformin HCl |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20100629 |
Marketing Category Name | ANDA |
Labeler Name | Heritage Pharmaceuticals Inc. |
Substance Name | GLIPIZIDE; METFORMIN HYDROCHLORIDE |
Strength Number | 2.5; 250 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |